Iron-Chelating Therapy and the Treatment of Thalassemia
Open Access
- 1 February 1997
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 89 (3) , 739-761
- https://doi.org/10.1182/blood.v89.3.739
Abstract
THE LAST 3 decades have witnessed profound changes in the management of patients with thalassemia major. Regular red blood cell (RBC) transfusions eliminate theKeywords
This publication has 241 references indexed in Scilit:
- Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis CThe Journal of Pediatrics, 1994
- Rapid removal of excessive iron with daily, high-dose intravenous chelation therapyThe Journal of Pediatrics, 1989
- Computed tomography scanning of the liver to determine efficacy of iron chelation therapy in thalassemia majorThe Journal of Pediatrics, 1989
- Deferoxamine-induced growth retardation in patients with thalassemia majorThe Journal of Pediatrics, 1988
- Non-transferrin-bound iron in long-term transfusion in children with congenital anemiasThe Journal of Pediatrics, 1986
- Growth and sexual maturation in thalassemia majorThe Journal of Pediatrics, 1985
- Clinical trial of young red cell transfusionsThe Journal of Pediatrics, 1984
- Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balanceThe Journal of Pediatrics, 1981
- Response to long-term deferoxamine therapy in thalassemiaThe Journal of Pediatrics, 1981
- Depressed serum somatomedin activity in β-thalassemiaThe Journal of Pediatrics, 1980